Trellis Vitality Review: $150 Sema, One Gap

Trellis Vitality (trellisvitality.com) sells five clinician-guided injectable programs, and its GLP-1 page does something almost nothing else in this market does: it publishes an actual table. One month, three months, six months, both molecules, every dose the same price, with the one-month column labeled as the month-to-month rate. We priced seven new telehealth sellers in August 2026 and this was the cleanest GLP-1 ladder of the lot. Then you click through to any other program and the pricing disappears.

The GLP-1 table, which is the good part

Semaglutide is $150 a month on the one-month plan, $140 a month over three, and $133 a month over six. Tirzepatide is $199, $189 and $179 across the same three columns.¹ The page states that longer plans cost less per month and that all dosages are available at the same price, and the one-month column really is month-to-month rather than a prepay total divided out — which is the single most common way a provider's cheapest-looking figure turns out to be unbuyable.

$150 month-to-month semaglutide is a strong number. Only Pepti beat it in this batch, and Pepti's own data disagrees with Pepti about what it charges.

The gap: four programs with a floor and no ceiling

NAD+, glutathione, Lipo-MIC + B12 and tesamorelin each publish one figure and stop: "treatment plans starting at" $129, $93, $130 and $299 a month respectively.¹ There is no rung table behind any of them. We pulled the site's build output and the intake payload looking for one and there is nothing there.

Do not read those as monthly prices, and we are not going to print them as if they were. Given that the GLP-1 table's six-month column sits about 12% below its one-month column, the likeliest reading is that these four figures are the longest-prepay rung and the true month-to-month rate is higher — but that is an inference from a neighboring product's structure, not something we observed. It stays unverified. If NAD+ is what you are shopping for, ask what one month costs before you commit to anything.

Worth knowing: Trellis's own blog states, twice, that the company publishes complete pricing on its program pages.² For GLP-1 that is true. For the other four programs it is not, and the blog does not distinguish.

The claims we are not repeating

Trellis's marketing carries a star rating, a current-patient count, an average-time-saved figure and an average-annual-saving figure. None of the four is sourced anywhere on the site — no methodology, no sample, no date. We are not reproducing them here, and you should discount them wherever you meet them. Transparency in our Match Score is scored on what a provider will let you check, not on what it asserts.

Who prescribes, who fills, and what is missing

Clinical work runs through Arora Health & Aesthetics, LLC, with Dr. Sean Arora as medical director; his NPI, 1841729449, resolves to an active Family Medicine record in the national registry.³ Dispensing goes to VialsRX, a compounding pharmacy in Houston, Texas, named outright.⁴ Naming both is good practice and most of this cohort manages neither.

Two things are missing. There is no legal entity published anywhere — the terms page runs to about three kilobytes of text and never says which company you are contracting with. And the "no membership, no consult costs" promise, along with the free assessment, is marketing copy that no terms document corroborates.

The other thing to know is that The Edit uses the same medical group and the same medical director as Trellis. Different pharmacy, different prices, different catalog — but they are one clinical organization. Shortlisting both looks like comparison and is not.

We queried FDA's live warning-letter index for the company, the medical group and the pharmacy. Nothing matched in the company column, on a pass that correctly returned a known 2026 letter for an unrelated control seller.⁵

Who this is a match for

You want a published, checkable GLP-1 price and you would rather have a mid-market rate you can verify than a headline you cannot. You are on tirzepatide, where $199 month-to-month is competitive and the three- and six-month columns actually save you money instead of locking you in at a worse rate — see tirzepatide cost without insurance for the surrounding market. You are in any of the 50 states. You value Speed to Start and Formulary Match less than you value knowing the number.

Who should walk away

You came for NAD+, glutathione, Lipo-MIC or tesamorelin, because for those four you cannot find out what you will pay without starting an intake. You need to know which legal entity you are contracting with. You already have The Edit on your list. Or you weight Budget Fit hardest and can live with the caveats attached to the cheaper rungs elsewhere in this batch. Either way, the quiz will reweight the six factors to you faster than a spreadsheet will.